CIK 0000064803 · Large accelerated filer
CVS HEALTH Corp
Sign in to watch- Ticker
- CVS
- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 050494040
- Phone
- 4017651500
- Business address
- ONE CVS DR., WOONSOCKET, RI, 02895
- Former names
- CVS CAREMARK CORP, CVS/CAREMARK CORP, CVS CORP, MELVILLE CORP
- Open-market buys, last 90 days
- $2,001,315
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,001,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-18 | BROWN C DAVID II Director | Grant or award · Share Credits | +1,437.38 | $69.31 | $100K | 74,674.45 |
| 2023-05-18 | DECOUDREAUX ALECIA A Director | Grant or award · Share Credits | +1,329.17 | $69.31 | $92K | 26,715.37 |
| 2023-05-03 | Lynch Karen S President and CEO | Purchase | +14,000 | $69.75 | $977K | 431,392 |
| 2023-04-01 | Shah Prem S EVP and Co-President of Retail | Shares withheld for taxes | −3,221 | $74.31 | $239K | 49,364.32 |
| 2023-04-01 | Shah Prem S EVP and Co-President of Retail | Grant or award · Stock Option | +89,073 | $74.31 | $6.6M | 89,073 |
| 2023-04-01 | PELUSO MICHELLE A EVP and Co-President of Retail | Shares withheld for taxes | −98,299 | $74.31 | $7.3M | 124,383 |
| 2023-04-01 | PELUSO MICHELLE A EVP and Co-President of Retail | Grant or award · Stock Option | +89,073 | $74.31 | $6.6M | 89,073 |
| 2023-04-01 | Mandadi Tilak EVP, Chief Technology Officer | Grant or award · Stock Option | +96,496 | $74.31 | $7.2M | 96,496 |
| 2023-04-01 | Lynch Karen S President and CEO | Shares withheld for taxes | −93,677 | $74.31 | $7.0M | 112,933 |
| 2023-04-01 | Lynch Karen S President and CEO | Grant or award · Stock Option | +244,952 | $74.31 | $18.2M | 244,952 |
| 2023-04-01 | Khichi Samrat S. EVP, CPO and General Counsel | Grant or award · Stock Option | +66,805 | $74.31 | $5.0M | 66,805 |
| 2023-04-01 | Joyner J. David EVP&President-PharmacyServices | Grant or award · Stock Option | +51,959 | $74.31 | $3.9M | 51,959 |
| 2023-04-01 | Havanec Laurie P. EVP and Chief People Officer | Grant or award · Stock Option | +51,959 | $74.31 | $3.9M | 51,959 |
| 2023-04-01 | GUERTIN SHAWN M EVP & Chief Financial Officer | Grant or award · Stock Option | +148,456 | $74.31 | $11.0M | 148,456 |
| 2023-04-01 | Finke Daniel P EVP/Pres, Health Care Benefits | Shares withheld for taxes | −3,856 | $74.31 | $287K | 35,067.81 |
| 2023-04-01 | Finke Daniel P EVP/Pres, Health Care Benefits | Grant or award · Stock Option | +74,228 | $74.31 | $5.5M | 74,228 |
| 2023-04-01 | Clark James David SVP, Cont & Chief Acct Officer | Shares withheld for taxes | −1,471 | $74.31 | $109K | 30,457.26 |
| 2023-04-01 | Clark James David SVP, Cont & Chief Acct Officer | Grant or award | +2,186 | $74.31 | $162K | 9,080 |
| 2023-04-01 | Clark James David SVP, Cont & Chief Acct Officer | Grant or award · Stock Option | +9,649 | $74.31 | $717K | 9,649 |
| 2023-04-01 | Chaguturu Sreekanth K EVP and Chief Medical Officer | Shares withheld for taxes | −1,854 | $74.31 | $138K | 6,427.63 |
Page 13 of 15 · 283 trades